HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Tuesday reported a loss of $2.9 million in its second quarter.
On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 64 cents. Losses, adjusted for non-recurring costs and amortization costs, came to 14 cents per share.
The medical instruments maker posted revenue of $22.7 million in the period.
For the current quarter ending in September, Harvard Bioscience said it expects revenue in the range of $21 million to $22.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HBIO at https://www.zacks.com/ap/HBIO
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
